Cargando…

Prognostic and diagnostic value of epithelial to mesenchymal transition markers in pulmonary neuroendocrine tumors

BACKGROUND: Pulmonary neuroendocrine tumors (Pulmonary NETs) include a wide spectrum of tumors, from the low-grade typical carcinoid (TC) and the intermediate-grade atypical carcinoid (AC), to the high-grade large-cell neuroendocrine carcinoma (LCNEC) and the small-cell carcinoma (SCLC). Epithelial...

Descripción completa

Detalles Bibliográficos
Autores principales: Galván, Jose A, Astudillo, Aurora, Vallina, Aitana, Crespo, Guillermo, Folgueras, Maria Victoria, González, Maria Victoria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4256901/
https://www.ncbi.nlm.nih.gov/pubmed/25413006
http://dx.doi.org/10.1186/1471-2407-14-855
_version_ 1782347646759862272
author Galván, Jose A
Astudillo, Aurora
Vallina, Aitana
Crespo, Guillermo
Folgueras, Maria Victoria
González, Maria Victoria
author_facet Galván, Jose A
Astudillo, Aurora
Vallina, Aitana
Crespo, Guillermo
Folgueras, Maria Victoria
González, Maria Victoria
author_sort Galván, Jose A
collection PubMed
description BACKGROUND: Pulmonary neuroendocrine tumors (Pulmonary NETs) include a wide spectrum of tumors, from the low-grade typical carcinoid (TC) and the intermediate-grade atypical carcinoid (AC), to the high-grade large-cell neuroendocrine carcinoma (LCNEC) and the small-cell carcinoma (SCLC). Epithelial Mesenchymal Transition (EMT) is a process initially recognised during several critical stages of embryonic development, which has more recently been implicated in promoting carcinoma invasion and metastasis. The initial stage of the EMT process begins with the deregulation of adhesion molecules, such as E-cadherin, due to transcriptional repression carried out by factors such as Snail family members, Twist and Foxc2. METHODS: Immunohistochemistry for EMT markers and E-cadherin/ β-catenin complex in 134 patients with pulmonary NETs between 1990 – 2009. Analysis of potential associations with clinicopathological variables and survival. RESULTS: Pulmonary NETs of high malignant potential (LCNEC and SCLC) had reduced expression of the adhesion molecules and high level expression of transcriptional repressors (Snail1, Snail2, Twist and Foxc2). Snail high expression levels and the loss of E-cadherin/β-catenin complex integrity had the strongest negative effect on the five-year survival rates. E-cadherin/β-catenin complex integrity loss independently predicted lymph node involvement and helped in Atypical Carcinoid (AC) vs Typical Carcinoid (TC) differential diagnosis. Importantly, among the TC group, the loss of E-cadherin/β-catenin complex integrity identified patients with an adverse clinical course despite favourable clinicopathological features. CONCLUSION: The immunohistochemical determination of E-cadherin/β-catenin complex integrity loss and EMT markers in the clinical setting might be a potential useful diagnostic and prognostic tool especially among the TC patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1471-2407-14-855) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4256901
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42569012014-12-06 Prognostic and diagnostic value of epithelial to mesenchymal transition markers in pulmonary neuroendocrine tumors Galván, Jose A Astudillo, Aurora Vallina, Aitana Crespo, Guillermo Folgueras, Maria Victoria González, Maria Victoria BMC Cancer Research Article BACKGROUND: Pulmonary neuroendocrine tumors (Pulmonary NETs) include a wide spectrum of tumors, from the low-grade typical carcinoid (TC) and the intermediate-grade atypical carcinoid (AC), to the high-grade large-cell neuroendocrine carcinoma (LCNEC) and the small-cell carcinoma (SCLC). Epithelial Mesenchymal Transition (EMT) is a process initially recognised during several critical stages of embryonic development, which has more recently been implicated in promoting carcinoma invasion and metastasis. The initial stage of the EMT process begins with the deregulation of adhesion molecules, such as E-cadherin, due to transcriptional repression carried out by factors such as Snail family members, Twist and Foxc2. METHODS: Immunohistochemistry for EMT markers and E-cadherin/ β-catenin complex in 134 patients with pulmonary NETs between 1990 – 2009. Analysis of potential associations with clinicopathological variables and survival. RESULTS: Pulmonary NETs of high malignant potential (LCNEC and SCLC) had reduced expression of the adhesion molecules and high level expression of transcriptional repressors (Snail1, Snail2, Twist and Foxc2). Snail high expression levels and the loss of E-cadherin/β-catenin complex integrity had the strongest negative effect on the five-year survival rates. E-cadherin/β-catenin complex integrity loss independently predicted lymph node involvement and helped in Atypical Carcinoid (AC) vs Typical Carcinoid (TC) differential diagnosis. Importantly, among the TC group, the loss of E-cadherin/β-catenin complex integrity identified patients with an adverse clinical course despite favourable clinicopathological features. CONCLUSION: The immunohistochemical determination of E-cadherin/β-catenin complex integrity loss and EMT markers in the clinical setting might be a potential useful diagnostic and prognostic tool especially among the TC patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1471-2407-14-855) contains supplementary material, which is available to authorized users. BioMed Central 2014-11-20 /pmc/articles/PMC4256901/ /pubmed/25413006 http://dx.doi.org/10.1186/1471-2407-14-855 Text en © Galván et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Galván, Jose A
Astudillo, Aurora
Vallina, Aitana
Crespo, Guillermo
Folgueras, Maria Victoria
González, Maria Victoria
Prognostic and diagnostic value of epithelial to mesenchymal transition markers in pulmonary neuroendocrine tumors
title Prognostic and diagnostic value of epithelial to mesenchymal transition markers in pulmonary neuroendocrine tumors
title_full Prognostic and diagnostic value of epithelial to mesenchymal transition markers in pulmonary neuroendocrine tumors
title_fullStr Prognostic and diagnostic value of epithelial to mesenchymal transition markers in pulmonary neuroendocrine tumors
title_full_unstemmed Prognostic and diagnostic value of epithelial to mesenchymal transition markers in pulmonary neuroendocrine tumors
title_short Prognostic and diagnostic value of epithelial to mesenchymal transition markers in pulmonary neuroendocrine tumors
title_sort prognostic and diagnostic value of epithelial to mesenchymal transition markers in pulmonary neuroendocrine tumors
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4256901/
https://www.ncbi.nlm.nih.gov/pubmed/25413006
http://dx.doi.org/10.1186/1471-2407-14-855
work_keys_str_mv AT galvanjosea prognosticanddiagnosticvalueofepithelialtomesenchymaltransitionmarkersinpulmonaryneuroendocrinetumors
AT astudilloaurora prognosticanddiagnosticvalueofepithelialtomesenchymaltransitionmarkersinpulmonaryneuroendocrinetumors
AT vallinaaitana prognosticanddiagnosticvalueofepithelialtomesenchymaltransitionmarkersinpulmonaryneuroendocrinetumors
AT crespoguillermo prognosticanddiagnosticvalueofepithelialtomesenchymaltransitionmarkersinpulmonaryneuroendocrinetumors
AT folguerasmariavictoria prognosticanddiagnosticvalueofepithelialtomesenchymaltransitionmarkersinpulmonaryneuroendocrinetumors
AT gonzalezmariavictoria prognosticanddiagnosticvalueofepithelialtomesenchymaltransitionmarkersinpulmonaryneuroendocrinetumors